Shareholding disclosure

Carnegie Fund II - Biotechbridge Sub Fund

Declared position

Threshold

Fell below threshold

Timeline

Published

07.07.2009

Transaction

30.06.2009

Transfer date

02.07.2009

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TC97600012

Beneficial owner

Carnegie Fund II - Biotechbridge Sub Fund

Declared address

Carnegie Fund II - Biotechbridge Sub-Fund, 1011 Luxembourg

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Carnegie Fund II - Biotechbridge Sub Fund

Santhera Pharmaceuticals Holding AG07.07.2009TC97600012

Disclosure summary

Carnegie Fund II - Biotechbridge Sub Fund disclosed a holding in Santhera Pharmaceuticals Holding AG that fell below the publication threshold, published by SIX Exchange Regulation on 07.07.2009, at 3% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Carnegie Fund II - Biotechbridge Sub Fund disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 07.07.2009.

Publication date07.07.2009

Transaction date30.06.2009

Transfer date02.07.2009

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerCarnegie Fund II - Biotechbridge Sub Fund

Declared addressCarnegie Fund II - Biotechbridge Sub-Fund, 1011 Luxembourg

CategoryCollective investment vehicle

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTC97600012

Source: SIX Exchange Regulation · Publication date: 07.07.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open